Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.
Five notes on the company’s financial performance for the third quarter of 2025:
1. Stryker reported an overall net sales increase of 10.3%, hitting $6.1 billion.
2. The company reported $3.8 billion in sales for its medical and surgical equipment and neurotechnology, a 14.4% increase.
3. Orthopedic net sales were $2.3 billion, a 3.9% increase.
4. Stryker reported net earnings of $859 million.
5. The company raised its full-year guidance for 2025, now expecting organic net sales growth between 9.8% and 10.2%.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
